| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.077 | 0.08 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.08 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.091 | 0.08 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.27 | 0.08 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.31 | 0.09 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |